Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Herrera Malaga Adolfo
  2. Issuer Name and Ticker or Trading Symbol
BENTLEY PHARMACEUTICALS INC [BNT]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) __X__ Other (specify below)
Managing Dir of European Sub
(Last)
(First)
(Middle)
2 HOLLAND WAY
3. Date of Earliest Transaction (Month/Day/Year)
07/22/2008
(Street)

EXETER, NH 03833
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.02 par value 07/22/2008   D   31,000 D (1) $ 14.8165 0 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (Right to Buy) $ 5.5096 07/22/2008   D     54,450 05/09/2002 05/09/2011 Common Stock, $0.02 par value 54,450 (2) 0 D  
Option (Right to Buy) $ 5.3949 07/22/2008   D     27,225 01/03/2001 01/03/2010 Common Stock, $0.02 par value 27,225 (3) 0 D  
Option (Right to Buy) $ 6.887 07/22/2008   D     25,410 03/30/2006 03/30/2015 Common Stock, $0.02 par value 25,410 (4) 0 D  
Option (Right to Buy) $ 6.887 07/22/2008   D     25,410 03/30/2007 03/30/2015 Common Stock, $0.02 par value 25,410 (5) 0 D  
Option (Right to Buy) $ 6.8872 07/22/2008   D     25,410 03/30/2008 03/30/2015 Common Stock, $0.02 par value 25,410 (6) 0 D  
Option (Right to Buy) $ 7.3921 07/22/2008   D     16,335 01/01/2004 01/01/2013 Common Stock, $0.02 par value 16,335 (7) 0 D  
Option (Right to Buy) $ 7.3921 07/22/2008   D     16,335 01/01/2005 01/01/2013 Common Stock, $0.02 par value 16,335 (8) 0 D  
Option (Right to Buy) $ 8.9899 07/22/2008   D     27,225 01/03/2003 01/03/2012 Common Stock, $0.02 par value 27,225 (9) 0 D  
Option (Right to Buy) $ 8.9899 07/22/2008   D     27,225 01/03/2004 01/03/2012 Common Stock, $0.02 par value 27,225 (10) 0 D  
Option (Right to Buy) $ 9.2195 07/22/2008   D     16,335 05/21/2004 05/21/2013 Common Stock, $0.02 par value 16,335 (11) 0 D  
Option (Right to Buy) $ 9.2195 07/22/2008   D     16,335 05/21/2005 05/21/2013 Common Stock, $0.02 par value 16,335 (12) 0 D  
Option (Right to Buy) $ 10.8124 07/22/2008   D     15,718 05/23/2007 05/23/2016 Common Stock, $0.02 par value 15,718 (13) 0 D  
Option (Right to Buy) $ 10.8124 07/22/2008   D     15,718 05/23/2008 05/23/2016 Common Stock, $0.02 par value 15,718 (14) 0 D  
Option (Right to Buy) $ 10.8131 07/22/2008   D     15,718 07/22/2008(15) 05/23/2016 Common Stock, $0.02 par value 15,718 (16) 0 D  
Option (Right to Buy) $ 10.9867 07/22/2008   D     18,150 05/23/2008 05/23/2017 Common Stock, $0.02 par value 18,150 (17) 0 D  
Option (Right to Buy) $ 10.9874 07/22/2008   D     36,300 07/22/2008(15) 05/23/2017 Common Stock, $0.02 par value 36,300 (18) 0 D  
Option (Right to Buy) $ 12.2132 07/22/2008   D     40,837 01/01/2005 01/01/2014 Common Stock, $0.02 par value 40,837 (19) 0 D  
Option (Right to Buy) $ 12.2129 07/22/2008   D     40,838 01/01/2006 01/01/2014 Common Stock, $0.02 par value 40,838 (20) 0 D  
Restricted Stock Units (21) 07/22/2008   D     11,978 07/22/2008(22)   (22) Common Stock, $0.02 par value 11,978 (21) 0 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Herrera Malaga Adolfo
2 HOLLAND WAY
EXETER, NH 03833
      Managing Dir of European Sub

Signatures

 /s/ Adolfo Herrera Malaga   07/24/2008
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Disposed of in connection with the merger of Beryllium Merger Corporation ("Acquisition Sub") with and into Bentley Pharmaceuticals, Inc. ("Bentley"), effective July 22, 2008 (the "Effective Time"), (the "Merger"), pursuant to the Agreement and Plan of Merger, dated as of March 31, 2008, by and among Bentley, Teva Pharmaceutical Industries, Ltd. and Acquisition Sub (the "Merger Agreement"). In connection with the Merger, each share of Common Stock listed in Table I was exchanged for the right to receive $14.8165, per share in cash.
(2) This option was cancelled in the Merger in exchange for a cash payment $506,758.43, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(3) This option was cancelled in the Merger in exchange for a cash payment $256,504.21, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(4) This option was cancelled in the Merger in exchange for a cash payment $201,489.77, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(5) This option was cancelled in the Merger in exchange for a cash payment $201,489.77, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(6) This option was cancelled in the Merger in exchange for a cash payment $201,482.27, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(7) This option was cancelled in the Merger in exchange for a cash payment $121,277.53, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(8) This option was cancelled in the Merger in exchange for a cash payment $121,277.53, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(9) This option was cancelled in the Merger in exchange for a cash payment $158,629.21, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(10) This option was cancelled in the Merger in exchange for a cash payment $158,629.21, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(11) This option was cancelled in the Merger in exchange for a cash payment $91,427.53, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(12) This option was cancelled in the Merger in exchange for a cash payment $91,427.53, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(13) This option was cancelled in the Merger in exchange for a cash payment $62,937.17, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(14) This option was cancelled in the Merger in exchange for a cash payment $62,937.17, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(15) Pursuant to the terms of the Merger Agreement, all options, whether or not exercisable or vested at the Effective Time, became, as of the Effective Time fully vested and exercisable.
(16) This option was cancelled in the Merger in exchange for a cash payment $62,925.40, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(17) This option was cancelled in the Merger in exchange for a cash payment $69,510.79, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(18) This option was cancelled in the Merger in exchange for a cash payment $138,997.64, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(19) This option was cancelled in the Merger in exchange for a cash payment $106,311.41, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(20) This option was cancelled in the Merger in exchange for a cash payment $106,326.23, representing the difference between the exercise price of the option and the merger consideration per share ($14.8165) multiplied by the total number of shares of Common Stock underlying the option.
(21) In connection with the Merger, each Restricted Stock Unit was converted into the right to receive $14.8165 per share in cash.
(22) Restricted Stock Units were granted under the terms of the Company's Amended and Restated 2005 Equity and Incentive Plan. Pursuant to the terms of the Merger Agreement, all restricted stock units, whether or not vested at the Effective Time, became, as of the Effective Time fully vested.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.